Home > Healthcare > Small Molecule Sterile Injectable Drugs Market

Small Molecule Sterile Injectable Drugs Market Share

Report ID: GMI9001
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Small Molecule Sterile Injectable Drugs Market Share

The small molecule sterile injectable drugs industry is highly competitive, marked by several players striving for market dominance. The pharmaceutical companies are offering a diverse portfolio of novel injectable formulations across various therapeutic areas. The companies are gaining traction through strategic expansions and product innovations. Pricing, product efficacy, regulatory compliance, and distribution networks remain critical factors influencing competitive dynamics.

Small Molecule Sterile Injectable Drugs Market Companies

Some of the eminent participants operating in the small molecule sterile injectable drugs industry include:

AbbVie Inc.
Amgen Inc.
AstraZeneca Plc.
BioCryst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company
Eisai Co., Ltd.
Eli Lilly and Company
Fresenius Kabi USA
Gilead Sciences, Inc.
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Small molecule sterile injectable drugs industry size recorded USD 154.6 billion in 2023 and is expected to register 7.1% CAGR from 2024 to 2032, due to the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders.

The chemotherapy agents segment in the market is estimated to accumulate USD 71.4 billion by 2032, owing to the high prevalence of cancer and the ongoing demand for effective chemotherapy options.

North America small molecule sterile injectable drugs industry is expected to expand at 6.9% CAGR from 2024 to 2032, on account of the robust healthcare infrastructure, high prevalence of chronic diseases, and a favorable regulatory environment.

AbbVie Inc., Amgen Inc., AstraZeneca Plc., BioCryst Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eisai Co., Ltd., Eli Lilly and Company, Fresenius Kabi USA, Gilead Sciences, Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. are some of the major small molecule sterile injectable drugs companies worldwide.